D

eveloping new drugs is a costly business. So, too, is paying for the ever more expensive therapies that come to market each year.

Statutorily, neither of those things is the Food and Drug Administration’s problem. But the agency’s new commissioner argues forcefully that the FDA can bring down drug prices for patients — by making life a little easier for Big Pharma.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • It is so painful to know that drugs are available but people is unable to have it due to affirdibikity and waiting otherwise to see pain of disease

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.